ProQR Therapeutics N.V. Equity Attributable To Owners Of Parent
ProQR Therapeutics N.V. (PRQR) had Equity Attributable To Owners Of Parent of EUR 49.37 million as of 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:EquityAttributableToOwnersOfParent · last filed 2026-03-12
- 2025-12-31: Equity Attributable To Owners Of Parent 49.37M EUR.
- 2025-09-30: Equity Attributable To Owners Of Parent 57.07M EUR.
- 2025-06-30: Equity Attributable To Owners Of Parent 66.98M EUR.
- 2025-03-31: Equity Attributable To Owners Of Parent 78.94M EUR.
| Period end | Equity Attributable To Owners Of Parent | Equity Attributable To Owners Of Parent as first filed |
|---|---|---|
| 2025-12-31 | 49.37M EUR 20-F · filed 2026-03-12 | |
| 2025-09-30 | 57.07M EUR 6-K · filed 2025-11-06 | |
| 2025-06-30 | 66.98M EUR 6-K · filed 2025-08-07 | |
| 2025-03-31 | 78.94M EUR 6-K · filed 2025-05-08 | |
| 2024-12-31 | 88.56M EUR 20-F · filed 2026-03-12 | |
| 2024-09-30 | 24.98M EUR 6-K · filed 2024-11-07 | |
| 2024-06-30 | 32.85M EUR 6-K · filed 2024-08-08 | |
| 2024-03-31 | 34.82M EUR 6-K · filed 2024-05-09 | |
| 2023-12-31 | 41.39M EUR 20-F · filed 2025-03-13 | |
| 2023-09-30 | 46.34M EUR 6-K · filed 2023-11-07 | |
| 2023-06-30 | 51.79M EUR 6-K · filed 2023-08-03 | |
| 2023-03-31 | 59.01M EUR 6-K · filed 2023-05-16 | |
| 2022-12-31 | 67.06M EUR 20-F · filed 2024-03-13 | 65.50M EUR 20-F · filed 2023-03-29 |
| 2022-09-30 | 64.92M EUR 6-K · filed 2022-11-09 | |
| 2022-06-30 | 87.37M EUR 6-K · filed 2022-08-04 | |
| 2022-03-31 | 100.83M EUR 6-K · filed 2022-05-05 | |
| 2021-12-31 | 113.83M EUR 20-F · filed 2023-03-29 | |
| 2021-09-30 | 128.61M EUR 6-K · filed 2021-11-04 | |
| 2021-06-30 | 118.11M EUR 6-K · filed 2021-08-05 | |
| 2020-12-31 | 57.09M EUR 20-F · filed 2022-04-29 | |
| 2020-09-30 | 68.63M EUR 6-K · filed 2020-11-16 | |
| 2020-06-30 | 80.09M EUR 6-K · filed 2020-08-06 | |
| 2020-03-31 | 81.87M EUR 6-K · filed 2020-05-07 | |
| 2019-12-31 | 94.33M EUR 20-F · filed 2021-03-24 | |
| 2019-09-30 | 59.87M EUR 6-K · filed 2019-11-12 | |
| 2019-06-30 | 70.63M EUR 6-K · filed 2019-08-07 | |
| 2018-12-31 | 92.92M EUR 20-F · filed 2020-03-31 | |
| 2018-06-30 | 22.87M EUR 6-K · filed 2018-08-08 | |
| 2017-12-31 | 39.36M EUR 20-F · filed 2019-03-28 | |
| 2016-12-31 | 53.14M EUR 20-F · filed 2018-03-30 |